Should We Buy a Competitor?
in Healthcare Providers

The short answer

Acquisitions fail on integration far more often than on price, and the integration cost of aligning cost-per-episode data across attributed lives is the number least likely to have been estimated. For healthcare providers, this shows up in a particular place. The numbers that carry the answer are cost per episode and payer mix, and the complication specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. The general version of this problem and the one you are actually in have different first moves.

The case for buying a competitor is usually built on combining attributed lives under value-based contracts, which are the least reliable category of benefit and the slowest to arrive. Contribution per provider and payer mix improvements are more predictable, and the honest ones are usually smaller than the model assumes.

The number that decides most outcomes is integration cost — aligning cost-per-episode records, merging panel operations, customer disruption, and the medical director attention diverted from existing attributed lives for a year or more. It is routinely omitted because it is hard to estimate and does not appear on either provider's accounts.

The disciplined version asks what specifically you get that you could not build or buy more cheaply another way, and what the attributed lives look like if none of the value-based contract synergies materialise.

How to tell this is actually your problem

These three together are the signature. One on its own usually points somewhere else.

✓ The rationale leans on expanding attributed lives through the other panel's payer mix
✓ Integration is described but cost per episode alignment is not costed
✓ The acquisition is partly motivated by the existing attributed lives having stalled contribution per provider

The move that usually makes it worse. Underwriting the deal on revenue synergies from value-based contracts, which typically arrive late, smaller than modelled, or not at all.

Who this is for — and who it is not

It is for you if you run or finance a healthcare provider and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.

It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.

What this looks like when the analysis is actually run

Below is an excerpt from a real run of this analysis on a healthcare provider. It is a sample profile rather than a customer, and it is unedited engine output — this is the format you get, on your own numbers.

The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.

This is one move out of a full analysis. Read a complete report — every page, no email required.

What the engine does with this question

This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For healthcare providers it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.

You watch the analysis get built before paying anything. Read a complete report here if you would rather see the depth first.

Questions people ask about this

How do I value a competitor?

Twice — once standalone, and once for what it is worth specifically to you. The gap between those is the most you can pay and still create value, and it is usually narrower than expected.

Are cost or revenue synergies more reliable?

Cost, substantially. They are within your control and can be scheduled. Revenue synergies depend on customers behaving as modelled, which is the assumption most often wrong.

What is the most common reason acquisitions fail?

Integration consuming more management attention than anyone budgeted, so that both businesses underperform during the period the deal was supposed to be paying back.

Is this different in healthcare providers than in other industries?

Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.

What data do I need before this analysis is worth running for a healthcare provider?

Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.

When is Percision the wrong tool?

Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.

Does Percision replace a lawyer, tax advisor, auditor, or AI implementation team?

Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.